R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

FT US Pharma and Biotech Summit 2025: Live coverage

We’re back this year, this time virtually attending the FT US Pharma and Biotech Summit in New York City, a one-day event where top pharma execs will come together to discuss the major tren

R&D

Multilateral benefit sharing mechanism for digital sequence ...

Since December 2022, and COP decision 15/9, members of the Convention on Biolog

R&D

Q1 Clinical trials round-up: Jan-Mar 2025

The first quarter of 2025 saw a wave of significant advancements in clinical research across oncology, neurology, dermatology, respiratory, and rare diseases.

R&D

graphic illustration of liver within human body on abstract background with DNA chain

Navigating the complexities of drug development in hepatolog...

In the realm of medical research, liver disease remains a complex and often overlooked field.

R&D

For cell therapies, raw material quality hinges on the human...

When it comes to cell-based therapy manufacturing, the concept of quality management carries important distinctions from more traditional therapeutics production.

R&D

female researchers looking at results on a computer screen

Driving innovation and improving patient outcomes through in...

Achieving diversity and inclusion in medical research is essential for advancing healthcare, discovering novel drug therapies, and achieving overall health equity.